Latest Mainsource Financial Group (MSFG)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Mainsource Financial Group (MSFG) Headlines

Upgrade Alert for MainSource Financial Group (MSFG)
Comtex SmarTrend(R) - Fri Jan 31, 7:17AM CST
MainSource Financial Group (NASDAQ:MSFG) was upgraded from Market Perform to Outperform at Raymond James today. The stock closed yesterday at $16.49 on volume of 35,000 shares, above average daily volume of 32,000. MainSource Financial Group (NASDAQ:MSFG) has potential upside of 15.2% based on a current price of $16.49 and analysts' consensus price target of $19.00. MainSource Financial Group shares should encounter resistance at the 50-day moving average (MA) of $16.91 and support at its 200-day MA of $15.09.

MainSource Financial Group -- NASDAQ, MSFG -- Announces Fourth Quarter and Full Year 2013 Operating Results and Increase to Common Dividend
Business Wire - Wed Jan 29, 3:00PM CST
--First quarter 2014 common stock dividend increased to $0.10 per share

Neutral on Associated Banc-Corp - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 06, 5:06PM CST
On Jan 2, 2014, we reaffirmed our long-term recommendation on Associated Banc-Corp at Neutral

Should You Stay Invested in Sallie Mae? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 24, 2:45PM CST
Shares of SLM Corporation closed at $25.95 on Dec 23, recording a year-to-date return of 53.1%.

Semi-Annual Changes to the NASDAQ OMX ABA Community Bank Index
GlobeNewswire - Mon Dec 16, 7:05AM CST
The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) today announced the results of the semi-annual evaluation of the NASDAQ OMX ABA Community Bank Index (Nasdaq:ABQI), which will become effective prior to market open on Monday, December 23, 2013.

U.S. Banks Stock Outlook - Dec 2013 - Industry Outlook
Kalyan Nandy - Zacks Investment Research - Thu Dec 12, 5:21PM CST
U.S. Banks Stock Outlook - Dec 2013 - Industry Outlook

U.S. Banks Stock Outlook - Dec 2013 - Zacks Analyst Interviews
Kalyan Nandy - Zacks Investment Research - Thu Dec 12, 5:21PM CST
U.S. Banks Stock Outlook - Dec 2013 - Zacks Analyst Interviews

Why Should You Stay Invested in Morgan Stanley? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 11, 12:38PM CST
Shares of Morgan Stanley have recorded a solid year-to-date return of 58.1%.

Should You Stay Invested in M&T Bank? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 09, 4:00PM CST
Shares of M&T Bank Corporation closed at $114.30 on Dec 6, recording a year-to-date return of 16.1%

Why Should You Stay Invested in Goldman? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 09, 12:37PM CST
Shares of The Goldman Sachs Group, Inc. closed at $167.21 on Dec 6, recording a year-to-date return of 28.7%.

24.9% Return Seen to Date on SmarTrend MainSource Financial Group Call (MSFG)
Comtex SmarTrend(R) - Mon Dec 09, 11:13AM CST
SmarTrend identified an Uptrend for MainSource Financial Group (NASDAQ:MSFG) on May 20th, 2013 at $13.77. In approximately 7 months, MainSource Financial Group has returned 24.91% as of today's recent price of $17.20.

Should You Stay Invested in Comerica (CMA)? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 05, 3:40PM CST
Shares of Comerica Incorporated have recorded a solid year-to-date return of 46.4%.

Wintrust Financial at New 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 05, 6:28AM CST
Shares of Wintrust Financial Corporation touched a new 52-week high of $46.00 during its trading session on Dec 4, reflecting an increase over the previous high of $45.77 reached on Nov 29.

MainSource Financial Group Up 28.4% Since SmarTrend Uptrend Call (MSFG)
Comtex SmarTrend(R) - Mon Dec 02, 9:51AM CST
SmarTrend identified an Uptrend for MainSource Financial Group (NASDAQ:MSFG) on May 20th, 2013 at $13.77. In approximately 7 months, MainSource Financial Group has returned 28.40% as of today's recent price of $17.68.

Should You Stay Invested in Commerce Bancshares? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 29, 3:25PM CST
Shares of Commerce Bancshares, Inc. have recorded a year-to-date return of 34.0%.

Commerce Bancshares Reaches 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 26, 2:10PM CST
Shares of Commerce Bancshares, Inc. hit a new 52-week high of $48.06 during the first half of the trading session on Nov 25.

MainSource Financial Group Has Returned 23.1% Since SmarTrend Recommendation (MSFG)
Comtex SmarTrend(R) - Mon Nov 25, 9:48AM CST
SmarTrend identified an Uptrend for MainSource Financial Group (NASDAQ:MSFG) on May 20th, 2013 at $13.77. In approximately 6 months, MainSource Financial Group has returned 23.09% as of today's recent price of $16.95.

First Interstate Bancsystem Hits 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 22, 9:00AM CST
Shares of First Interstate Bancsystem Inc. crafted a new 52-week high, touching $26.60 at the end of the trading session on Nov 21.

PrivateBancorp Reaches 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 15, 11:40AM CST
Shares of PrivateBancorp, Inc. hit a new 52-week high, touching $26.52 almost at the end of trading session on Nov 14.

MainSource Financial Group (MSFG) Stock Research Links

MSFG Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

FLUX 3 Max Launches with Unmatched Speed and Quality

Updated Category News Views 19

A Lightning Fast Leap in Video Generation It's all eyes on FLUX 3 Max today. You can almost hear the gasps of 'wow' in the generative media crowd. Why? Because this new weapon in the video gen arsenal, dreamed up by fal and Black Forest Labs, is slicing through the old speed limits like a blistering comet. Now, don't get me wrong. Seeds don't grow overnight, and neither...

Continue Reading
CMS Proposal Sparks Controversy in Lab Certification

Updated Category News Views 8

A New Contender in the Battle Over Lab Standards Here's what’s heating up in the realm of clinical laboratories: A proposed shift by the Centers for Medicare & Medicaid Services (CMS) that reeks of cutting corners, if you ask the folks at the Association for Diagnostics & Laboratory Medicine (ADLM). They’re banging the drums against CMS's idea to nix the board...

Continue Reading
INSPIRE 2026: Luxury Hotel Trends and Investments

Updated Category News Views 7

Luxury Hotels: Where's the Money Headed? All eyes on Orlando this December 15–16, where the International Luxury Hotel Association (ILHA) is calling the shots. INSPIRE 2026 is the marquee event of the year for luxury hospitality, and it ain't just about starry chandeliers and velvet drapes. We're talking real capital shifts, margins pinching tighter, and a future...

Continue Reading
Endava Faces Securities Fraud Lawsuit: Investor Implications

Updated Category News Views 8

Endava in Hot Water Over Alleged Misleading Statements Alright, folks, gather around—there's a storm brewing over at Endava with shareholders mightier than the Greek gods, furrowing their brows with intent. You see, Schall, Brown & Schwartz LLP, a firm that practically eats legal challenges for breakfast, is beating the drums of a securities fraud lawsuit. Yep, I'm...

Continue Reading
PG&E Delivers $26M Climate Credit to Small Biz

Updated Category News Views 2

California's Big Move for Small Businesses In a world where every dollar counts, small businesses across Northern and Central California are getting a helping hand. Pacific Gas and Electric Company (PG&E) is stepping up with a tidy little climate credit thanks to the state's Cap-and-Invest Program. Eligible businesses are automatically set to receive a $36.18 credit off...

Continue Reading
Brown Plus Ranks #8 Best Workplace for Women 2026

Updated Category News Views 5

Cracking the Top Ten: A Noteworthy Feat When it comes to hustling and bustling in the corporate world, Brown Plus managed to snag the spotlight by landing the #8 spot in the 'Best Place to Work for Women 2026.' It's a title they didn't just stumble upon. This recognition in the medium category by the Best Companies Group underscores the fact that Brown Plus is running its...

Continue Reading
Kenneth Smith Takes Helm for Trends Int’l Expansion

Updated Category News Views 12

Tired of the Same Old Leadership Shuffle? Here Comes Kenneth Smith Look, I’ve seen my share of execs come and go, usually dragging the same old briefcase of stale ideas. But Kenneth Smith stepping up as CEO of Trends International? Now that’s got some real teeth to it. Come May 2026, he’s the guy at the helm, and he's got one hell of a to-do list. Smith's Roadmap: A...

Continue Reading
JELD-WEN CFO Transition: Navigating Finances Amid Changes

Updated Category News Views 6

Leadership Shake-up at JELD-WEN Alright, folks, the boardroom saga over at JELD-WEN just took another spin. Samantha Stoddard, the brain behind the numbers as Chief Financial Officer, is packing her bags come mid-November. Yeah, she's off to chase new horizons outside the realm of building products, leaving a spot hotter than a New York Stock Exchange ring bell up for...

Continue Reading
Hyliion Legal Woes Shake Investor Confidence

Updated Category News Views 2

Legal Storm Brews Over Hyliion Investments If you think riding the stock market is like sailing a calm sea, wake up. Hyliion Holdings Corp. (NYSE:HYLN) finds itself steaming headlong into rough waters. A securities class action lawsuit, Olmeta v. Hyliion Holdings Corp., accuses the company of embellishing its ambitions. The lawsuit cites potential wrongdoing in a...

Continue Reading
Flotek Faces Class Action as PREPA Contract Dissolves

Updated Category News Views 0

Flotek's 10-Year Project Shattered by Canceled Agreement Here's a brew you won't find down at any greasy spoon: Flotek Industries (NYSE: FTK) finds itself tangled in a legal web after their highly touted project in Puerto Rico went belly-up. That's one heck of a slice off their revenue pie, and investors best have their radar turned on. The lawsuit's all about what's...

Continue Reading

Top 5 Most Recently Viewed Articles

Nektar Therapeutics Announces Key Stock Option Grants for New Employees

Updated Category News Views 124

Nektar Therapeutics' New Stock Option Grants for Employees Nektar Therapeutics (NASDAQ: NKTR) has made an important announcement regarding the granting of stock options designed to attract new talent. Recently, their Board of Directors revealed that, under its 2025 Inducement Plan, they granted a considerable number of stock options aimed at supporting the interests of a...

Continue Reading
B2Gold Celebrates Successful Commercial Launch of Goose Mine

Updated Category News Views 157

Exciting Developments at the Goose Mine VANCOUVER, British Columbia -- B2Gold Corp. (TSX: BTO, NYSE AMERICAN: BTG, NSX: B2G) is thrilled to share that the Goose Mine has officially achieved commercial production, marking a significant milestone for the company. Production Milestone and Operations Update The declaration of commercial production at the Goose Mine came after...

Continue Reading
Tesla's Optimus Robot Advances in Autonomous Capabilities

Updated Category News Views 410

Tesla's Optimus Robot Takes Strides in Autonomy Tesla Inc. recently unveiled a captivating video showcasing its Optimus humanoid robot deftly navigating a factory environment. This demonstration emphasizes significant advancements in the robot's technology, particularly its autonomous navigation and charging capabilities. Robust Navigation Skills The latest video...

Continue Reading
monday.com Set to Reveal Financial Performance for 2024

Updated Category News Views 113

monday.com Financial Results Announcement monday.com (NASDAQ: MNDY), the innovative platform that enhances work management, has highlighted its commitment to transparency and investor engagement. The company has announced an upcoming report on its financial results for the fourth quarter and fiscal year 2024. This key announcement is scheduled for the morning of February...

Continue Reading
BioCryst Pharmaceuticals Holds Strong Position for Investors

Updated Category News Views 34

BioCryst Pharmaceuticals Maintains Strong Market Position Recently, BofA Securities reiterated its Buy rating for BioCryst Pharmaceuticals (NASDAQ:BCRX), maintaining a price target of $11.00. This assessment came on the heels of an encouraging third-quarter earnings report, where Orladeyo sales hit $116.3 million, surpassing expectations set by both BofA and market...

Continue Reading